About us
Understand the story and mission of AfireGene
Founded in 2019, Shenzhen AfireGene Technology Co., Ltd. focuses on the translational application of ultra early molecular detection technology in the field of disease screening and diagnosis, covering two major business directions, genomics and the application of IVD products for disease early screening based on omics development.
With advanced technology and experienced team, we have won the trust of many customers and strive to improve everyone's quality of life.


Application direction of IVD products for disease early screening:
Disease early screening IVD product application direction, launch the C-end product series safety tester suitable for public health ™, This series mainly distributes POCT products, including tumor early screening, early detection of pathogen infection (HPV, HIV, HP, HBV, EBV, covid-19, H5N1 avian influenza) and other rapid detection products.

